ArticleTranslational cancer research2024

Efficacy and safety of anlotinib in combination with immune checkpoint inhibitors or not as advanced non-small cell lung cancer treatment: a systematic review and network meta-analysis.

Zhengyu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.